FA recently asked experts on their experience working on the first listing under HKEX’s newly introduced Chapter 18C for tech firms in the new economy.
UBS and Macquarie’s Australasia-based teams advised the aged care firm on use of proceeds for its recent equity raise, new capital structure and related disclosure considerations.
Katherine Wang joins as counsel in the Life Sciences practice in Shanghai, which is an advisor to the government on the drafting of new drug and device laws in China.